Interní Med. 2016; 18(3): 146-149 | DOI: 10.36290/int.2016.034

Successful ultrasound-guided percutaneous ethanol ablation of an parathyroid adenoma of ninety-year-old senior

MUDr. Milan Halenka, Ph.D.1, doc. MUDr. Zdeněk Fryšák, CSc.1, doc. MUDr. David Karásek, Ph.D.1, doc. MUDr. Pavel Koranda, Ph.D.2, MUDr.Iva Metelková, Ph.D.2
1 III. interní klinika &ndash, nefrologická, revmatologická, endokrinologická, FN a LF UP Olomouc
2 Klinika nukleární medicíny, FN a LF UP v Olomouci

Percutaneous Ethanol Injection Therapy of parathyroid adenoma under ultrasound guidance is individually used as an alternative

procedure in management of primary hyperparathyroidism in polymorbid elderly patients with increased surgical risk. We

present a case of a 92-year-old male patient, who underwent thyroidectomy for papillary thyroid carcinoma three years ago. Part

of the regular annual follow-up visits was also ultrasonography, which showed a solitary parathyroid adenoma at the site of the

removed thyroid gland. Given the underlying condition, polymorbidity and age of the patient, the PEIT method was successfully

used in the therapy. The coincidence of adenoma and papillary thyroid carcinoma is also interesting.

Keywords: parathyroid adenoma, Percutaneous Ethanol Injection Therapy, papillary thyroid carcinoma

Published: July 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Halenka M, Fryšák Z, Karásek D, Koranda P, Metelková I. Successful ultrasound-guided percutaneous ethanol ablation of an parathyroid adenoma of ninety-year-old senior. Interní Med. 2016;18(3):146-149. doi: 10.36290/int.2016.034.
Download citation

References

  1. Fraser WD. Hyperparathyroidism. Lancet 2009; 374: 145-158. Go to original source...
  2. Bilezikian JP, Khan AA, Potts JT Jr; Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009; 94: 335-339. Go to original source...
  3. Broulík P, Adámek S, Libánský P, Tvrdoň J. Diagnosis and treatment of primary hyperparathyroidism. Interní Med 2007; 3: 130-132.
  4. Karstrup S, Hegedüs L, Holm HH. Acute change in parathyroid function in primary hyperparathyroidism following ultrasonically guided ethanol injection into solitary parathyroid adenomas. Acta Endocrinol (Copenh) 1993; 129: 377-380. Go to original source... Go to PubMed...
  5. Solbiati L, Giangrande A, De Pra L, Bellotti E, Cant? P, Ravetto C. Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology 1985; 155: 607-610. Go to original source... Go to PubMed...
  6. Müller-Gärtner HW, Beil FU, Schneider C, Ringe JD, Greten H. Percutaneous transthyroidal instillation treatment of parathyroid adenoma with ethanol in primary hyperparathyroidism. Dtsch Med Wochenschr 1987; 112: 1459-1461. Go to original source...
  7. Charboneau JW, Hay ID, van Heerden JA. Persistent primary hyperparathyroidism: successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma. Mayo Clin Proc 1988; 63: 913-917. Go to original source... Go to PubMed...
  8. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 2014; 99: 3561-3569. Go to original source...
  9. Karstrup S, Transb?l I, Holm HH, Glenth?j A, Hegedüs L. Ultrasound-guided chemical parathyroidectomy in patients with primary hyperparathyroidism: a prospective study. Br J Radiol 1989; 62: 1037-1042. Go to original source...
  10. Harman CR, Grant CS, Hay ID, Hurley DL, van Heerden JA, Thompson GB, Reading CC, Charboneau JW. Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery 1998; 124: 1011-1019. Go to original source... Go to PubMed...
  11. Cercueil JP, Jacob D, Verges B, Holtzmann P, Lerais JM, Krause D. Percutaneous ethanol injection into parathyroid adenomas: mid- and long-term results. Eur Radiol 1998; 8: 1565-1569. Go to original source...
  12. Stratigis S, Stylianou K, Mamalaki E, Perakis K, Vardaki E, Tzenakis N, Katsipi I, Papavasiliou S, Yarmenitis S, Kyriazis J, Daphnis E. Percutaneous ethanol injection therapy: a surgery-sparing treatment for primary hyperparathyroidism. Clin Endocrinol (Oxf) 2008; 69: 542-548. Go to original source... Go to PubMed...
  13. Wagner B, Begic-Karup S, Raber W, Schneider B, Waldhäusl W, Vierhapper H. Prevalence of primary hyperparathyroidism in 13387 patients with thyroid diseases, newly diagnosed by screening of serum calcium. Exp Clin Endocrinol Diabetes 1999; 107: 457-461. Go to original source...
  14. Morita SY, Somervell H, Umbricht CB, Dackiw AP, Zeiger MA. Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery 2008; 144: 862-866. Go to original source... Go to PubMed...
  15. Linos DA, van Heerden JA, Edis AJ. Primary hyperparathyroidism and nonmedullary thyroid cancer. Am J Surg 1982; 143: 301-303. Go to original source... Go to PubMed...
  16. Milas M, Mensah A, Alghoul M, Berber E, Stephen A, Siperstein A, Weber CJ. The impact of office neck ultrasonography on reducing unnecessary thyroid surgery in patients undergoing parathyroidectomy. Thyroid 2005; 15: 1055-1059. Go to original source... Go to PubMed...
  17. Webový portál: GLOBOCAN, IARC. www.globocan.iarc.fr
  18. Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol 2011; 5: 51-56. Go to original source...
  19. Schneider DF, Chen H, Sippel RS. Impact of lymph node ratio on survival in papillary thyroid cancer. Ann Surg Oncol 2013; 20: 1906-1911. Go to original source...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.